Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

<p>Abstract</p> <p>Background</p> <p>Patients with metastatic breast cancer are frequently treated with anthracyclines and taxanes, which are among the most active agents in this disease. Gemcitabine is an interesting candidate for a three-drug combination because of it...

Full description

Bibliographic Details
Main Authors: Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Format: Article
Language:English
Published: BMC 2006-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/6/76

Similar Items

Similar Items